BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3420254)

  • 1. Contrast medium-induced adverse reactions: economic outcome.
    Powe NR; Steinberg EP; Erickson JE; Moore RD; Smith CR; White RI; Brinker JA; Fishman EK; Zinreich SJ; Kinnison ML
    Radiology; 1988 Oct; 169(1):163-8. PubMed ID: 3420254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency and determinants of adverse reactions induced by high-osmolality contrast media.
    Moore RD; Steinberg EP; Powe NR; White RI; Brinker JA; Fishman EK; Zinreich SJ; Smith CR
    Radiology; 1989 Mar; 170(3 Pt 1):727-32. PubMed ID: 2916027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse reactions to contrast media: factors that determine the cost of treatment.
    Powe NR; Moore RD; Steinberg EP
    AJR Am J Roentgenol; 1993 Nov; 161(5):1089-95. PubMed ID: 8273616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-osmolality contrast media: good news or bad?
    Evens RG
    Radiology; 1988 Oct; 169(1):277-8. PubMed ID: 3138706
    [No Abstract]   [Full Text] [Related]  

  • 5. Selective use of low-osmolality contrast agents for i.v. urography and CT: safety and effect on cost.
    Hunter TB; Dye J; Duval JF
    AJR Am J Roentgenol; 1994 Oct; 163(4):965-8. PubMed ID: 8092044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cost-effectiveness of replacing high-osmolality with low-osmolality contrast media.
    Caro JJ; Trindade E; McGregor M
    AJR Am J Roentgenol; 1992 Oct; 159(4):869-74. PubMed ID: 1529856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Net costs from three perspectives of using low versus high osmolality contrast medium in diagnostic angiocardiography.
    Powe NR; Davidoff AJ; Moore RD; Brinker JA; Anderson GF; Litt MR; Gopalan R; Graziano SL; Steinberg EP
    J Am Coll Cardiol; 1993 Jun; 21(7):1701-9. PubMed ID: 8496540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and cost effectiveness of high-osmolality as compared with low-osmolality contrast material in patients undergoing cardiac angiography.
    Steinberg EP; Moore RD; Powe NR; Gopalan R; Davidoff AJ; Litt M; Graziano S; Brinker JA
    N Engl J Med; 1992 Feb; 326(7):425-30. PubMed ID: 1732769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of low-osmolality contrast media in a price-sensitive environment.
    Steinberg EP; Anderson GF; Powe NR; Sakin JW; Kinnison ML; Neuman P; White RI
    AJR Am J Roentgenol; 1988 Aug; 151(2):271-4. PubMed ID: 3260719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The safety and cost-effectiveness of low osmolar contrast media. Can economic analysis determine the real worth of a new technology?
    Henry DA; Evans DB; Robertson J
    Med J Aust; 1991 Jun; 154(11):766-72. PubMed ID: 1828529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of nonionic, low-osmolality radiocontrast agents with ionic, high-osmolality agents during cardiac catheterization.
    Barrett BJ; Parfrey PS; Vavasour HM; O'Dea F; Kent G; Stone E
    N Engl J Med; 1992 Feb; 326(7):431-6. PubMed ID: 1732770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nephrotoxicity of high-osmolality versus low-osmolality contrast media: randomized clinical trial.
    Moore RD; Steinberg EP; Powe NR; Brinker JA; Fishman EK; Graziano S; Gopalan R
    Radiology; 1992 Mar; 182(3):649-55. PubMed ID: 1535876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High and low osmolar contrast media: who pays?
    Göthlin JH
    Eur J Radiol; 1988 May; 8(2):67-8. PubMed ID: 3383859
    [No Abstract]   [Full Text] [Related]  

  • 14. Radiocontrast-associated renal dysfunction: a comparison of lower-osmolality and conventional high-osmolality contrast media.
    Lautin EM; Freeman NJ; Schoenfeld AH; Bakal CW; Haramati N; Friedman AC; Lautin JL; Braha S; Kadish EG
    AJR Am J Roentgenol; 1991 Jul; 157(1):59-65. PubMed ID: 2048540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic impact of low-osmolality contrast agents on radiology procedures and departments.
    Evens RG
    Radiology; 1987 Jan; 162(1 Pt 1):267-8. PubMed ID: 3786775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indications for the use of low-osmolar contrast agents.
    Bloom DM
    Physician Exec; 1989; 15(4):24-5. PubMed ID: 10313370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Adverse reactions to low osmolar iodine contrast media (second report)].
    Kuwatsuru R; Katayama H; Tomita T; Naoi Y; Hirano A; Miyauchi T; Takeuchi N; Ozaki Y; Nakanishi A; Sumie H
    Nihon Igaku Hoshasen Gakkai Zasshi; 1992 Sep; 52(9):1233-46. PubMed ID: 1437529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Miscellaneous adverse effects of low-versus high-osmolality contrast media: a study revised.
    Brismar J; Jacobsson BF; Jorulf H
    Radiology; 1991 Apr; 179(1):19-22. PubMed ID: 1826061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonionic contrast media: economic analysis and health policy development.
    Goel V; Deber RB; Detsky AS
    CMAJ; 1989 Feb; 140(4):389-95. PubMed ID: 2492446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decision analysis to assess cost-effectiveness of low-osmolality contrast medium for intravenous urography.
    Calvo MV; Pilar del Val M; Mar Alvarez M; Domínguez-Gil A
    Am J Hosp Pharm; 1992 Mar; 49(3):577-84. PubMed ID: 1598930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.